Sleep quality, anxiety and depression in advanced lung cancer: patients and caregivers
Yuan He(Xuzhou Medical College), Changxuan You(Southern Medical University), Ling Deng(Sun Yat-sen University), Tao Tang(Chinese University of Hong Kong), Kunwei Peng(Sun Yat-sen University Cancer Center), Li‐Yue Sun(Sun Yat-sen University), Man-Jun Luo(Nanfang Hospital)
Cited by 64
Related Papers
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
|The Lancet Oncology|2011|4.1k
Multifunctional biohybrid magnetite microrobots for imaging-guided therapy
|Science Robotics|2017|873
Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802)
|Annals of Oncology|2015|467
ALKBH5 Inhibits Pancreatic Cancer Motility by Decreasing Long Non-Coding RNA KCNK15-AS1 Methylation
|Cellular Physiology and Biochemistry|2018|294
Magnetite Nanostructured Porous Hollow Helical Microswimmers for Targeted Delivery
|Advanced Functional Materials|2015|278